A 12-year-old boy with fatal hemolytic-uremic-syndrome, excessive neutrophilia and elevated endogenous granulocyte-colony-stimulating-factor serum concentrations
- PMID: 9710348
A 12-year-old boy with fatal hemolytic-uremic-syndrome, excessive neutrophilia and elevated endogenous granulocyte-colony-stimulating-factor serum concentrations
Abstract
We report the case of a 12-year-old boy with fatal enteropathic hemolytic-uremic syndrome who developed excessive neutrophilia in the course of his disease, his leukocyte count exceeding 200,000/mm3. Neutrophilia, as it was observed in this case, is an extreme manifestation of a phenomenon, that is commonly observed in hemolytic-uremic syndrome [Salzmann et al. 1991]. Neutrophilia is suspected to be correlated with a bad prognosis [Walters et al. 1989], but further explanation of this phenomenon is needed. Other underlying diseases related with neutrophilia, especially hematologic malignancies, could be ruled out by far. We examined endogenous G-CSF serum concentrations of the HUS patient from day 6 to 13 in the course of the disease. The assayed concentrations were found to be elevated in the first two samples taken (peak level 340 pg/ml). In the samples taken after plasmapheresis had started, G-CSF concentrations were not found to be elevated. The peak of neutrophilia was reached short before death on day 13 of the disease. We also measured the serum G-CSF concentrations of 28 children aged 3 months to 12 years, who were treated with various infectious and noninfectious diseases in our hospital. In none of the examined samples was there a G-CSF serum concentration exceeding 50 pg/ml. The reported case shows evidence that the commonly observed coincidence of leukocytosis and HUS may reflect the role of G-CSF (and other cytokines) in the inflammatory process underlying the HUS.
Similar articles
-
Elevated granulocyte colony-stimulating factor, non-infectious leukocytosis and fevers in a patient with multiple myeloma.J Gen Intern Med. 2008 Dec;23(12):2134-5. doi: 10.1007/s11606-008-0789-4. Epub 2008 Sep 23. J Gen Intern Med. 2008. PMID: 18810556 Free PMC article.
-
Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.Haematologica. 1994 Jan-Feb;79(1):7-12. Haematologica. 1994. PMID: 15378942
-
Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction.Arch Dermatol. 2004 May;140(5):570-4. doi: 10.1001/archderm.140.5.570. Arch Dermatol. 2004. PMID: 15148101
-
[Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia].Rinsho Ketsueki. 2004 Mar;45(3):228-32. Rinsho Ketsueki. 2004. PMID: 15103937 Review. Japanese.
-
[Bladder cancer producing granulocyte colony-stimulating factor (G-CSF): a case report].Hinyokika Kiyo. 2002 Aug;48(8):495-8. Hinyokika Kiyo. 2002. PMID: 12243077 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials